Migraines Approved Under Connecticut’s Medical Marijuana Program
Connecticut’s Medical Marijuana Program is on its way to adding three more conditions to their five-year-old plan. Intractable migraines, along with Hydrocephalus, a brain blockage that causes headaches and Trigeminal Neuralgia, a condition that causes facial nerve pain, have all been approved by the program’s board of physicians as a qualifying condition.
The board’s list of conditions moved on to the commissioner of the Department of Consumer Protection, Michelle H. Seagull who approved the recommendations of the program’s Board of Physicians on June 9. The drafts will now proceed to the next round of approvals, which includes a public hearing and comments section. In a statement, Seagull also said the regulation would be reviewed by the Office of the Attorney General and, “ultimately require the approval of the Regulation Review Committee of the General Assembly.”
The decision comes after a public hearing last Friday, where testimonies were given regarding recommendations for the medical cannabis program.
While there were ailments that didn’t make the list like, certain anxiety related disorders and Meniere’s disease, which targets the inner ear and is known to cause vertigo, the commissioner did make very clear the thoughtful consideration each recommendation did get saying, “We value, and care very deeply about input from patients, and the medical community. We’re proud that our program continues its thoughtful expansion through processes like these public hearings. I want to thank those who testified for attending yesterday’s meeting, and the Board of Physicians for their service and recommendations.”
The three approved disorders along with four others that were approved just this past February including, fibromyalgia, rheumatoid arthritis, shingles and muscular dystrophy, which are a welcome addition to the 22 conditions that Connecticut offers medical cannabis. There are also six conditions approved for patients under the age of 18 that that use an extracted from of CBD.
Under Connecticut’s Medical Marijuana Program, there are currently 18,198 patients receiving treatment under the care of 693 registered physicians.
